| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047984892 |
| P356 | DOI | 10.1038/NATURE20411 |
| P932 | PMC publication ID | 5172605 |
| P698 | PubMed publication ID | 27830812 |
| P50 | author | Tony Wyss-Coray | Q23782672 |
| P2860 | cites work | Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. | Q53369656 |
| The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870–1900 | Q56851491 | ||
| DNA methylation age of human tissues and cell types | Q21183994 | ||
| TREM2 Variants in Alzheimer's Disease | Q22250873 | ||
| Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| The ageing systemic milieu negatively regulates neurogenesis and cognitive function. | Q24599219 | ||
| Meta‐analysis of genetic variants associated with human exceptional longevity | Q24605503 | ||
| Distinct DNA methylation changes highly correlated with chronological age in the human brain | Q24616264 | ||
| Protective effects of NSAIDs on the development of Alzheimer disease | Q24656148 | ||
| Suspected non-Alzheimer disease pathophysiology--concept and controversy | Q26771270 | ||
| Blood-Borne Revitalization of the Aged Brain | Q26799718 | ||
| β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis | Q27315300 | ||
| The hallmarks of aging | Q28131641 | ||
| Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle | Q28239514 | ||
| Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors | Q28239524 | ||
| Neuroinflammation in Alzheimer's disease | Q28259238 | ||
| Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy | Q28290417 | ||
| The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice | Q28591283 | ||
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins | Q44917427 | ||
| Age-related myelin degradation burdens the clearance function of microglia during aging. | Q46707647 | ||
| Effect of exercise training on plasma visfatin and eotaxin levels | Q46983590 | ||
| Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. | Q50646784 | ||
| Genetic influence on human lifespan and longevity. | Q51820158 | ||
| Anti-inflammatory drugs and Alzheimer disease. | Q53183421 | ||
| Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease. | Q53328363 | ||
| GWAS analysis of handgrip and lower body strength in older adults in the CHARGE consortium | Q28596242 | ||
| Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset | Q28730795 | ||
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease | Q28943325 | ||
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease | Q29614879 | ||
| Rejuvenation of aged progenitor cells by exposure to a young systemic environment | Q29615250 | ||
| Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor | Q29615559 | ||
| mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies. | Q30539812 | ||
| Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH | Q30543829 | ||
| Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. | Q30597164 | ||
| Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. | Q30832612 | ||
| Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. | Q31063014 | ||
| Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. | Q32062012 | ||
| Systemic inflammation and disease progression in Alzheimer disease | Q33765718 | ||
| The epigenetic landscape of Alzheimer's disease. | Q33802600 | ||
| Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity | Q33811539 | ||
| Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases | Q34040980 | ||
| The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review | Q34074186 | ||
| Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging | Q34117787 | ||
| A pathophysiological framework of hippocampal dysfunction in ageing and disease | Q34214060 | ||
| Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies | Q34281671 | ||
| The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. | Q34395093 | ||
| Plasma based markers of [11C] PiB-PET brain amyloid burden | Q34427001 | ||
| Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci | Q34433829 | ||
| Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease | Q34433837 | ||
| Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease | Q34463543 | ||
| Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients | Q34504712 | ||
| Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation | Q34520504 | ||
| Deep biomarkers of human aging: Application of deep neural networks to biomarker development | Q34527074 | ||
| Plasma proteins predict conversion to dementia from prodromal disease | Q34556953 | ||
| The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis | Q34621569 | ||
| A Comprehensive Profile of ChIP-Seq-Based PU.1/Spi1 Target Genes in Microglia | Q34672284 | ||
| Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease | Q34985170 | ||
| Proinflammatory cytokines, sickness behavior, and Alzheimer disease | Q35104455 | ||
| Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. | Q35497573 | ||
| Circulating Proteomic Signatures of Chronological Age. | Q35746977 | ||
| Exposure to a youthful circulaton rejuvenates bone repair through modulation of β-catenin | Q35775341 | ||
| Young, proliferative thymic epithelial cells engraft and function in aging thymuses | Q35783525 | ||
| Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array | Q35951935 | ||
| Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study | Q35966448 | ||
| Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease | Q36183810 | ||
| Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging | Q36197707 | ||
| The epidemiology of longevity and exceptional survival | Q36449872 | ||
| Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease. | Q36594535 | ||
| CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging | Q36598397 | ||
| Novel loci and pathways significantly associated with longevity | Q36615898 | ||
| Altered Proteins in the Aging Brain | Q36692073 | ||
| Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI. | Q36796489 | ||
| Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants | Q36802036 | ||
| Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain | Q36836566 | ||
| Whole-Genome Sequencing of a Healthy Aging Cohort | Q36880280 | ||
| Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease | Q36914722 | ||
| Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease | Q36932748 | ||
| Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. | Q37020043 | ||
| Rejuvenation of regeneration in the aging central nervous system | Q37023170 | ||
| Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial | Q37151258 | ||
| Immune activation in brain aging and neurodegeneration: too much or too little? | Q37617634 | ||
| Microglial dysfunction in brain aging and Alzheimer's disease | Q37678533 | ||
| Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype | Q37886047 | ||
| Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. | Q38012092 | ||
| Immunotherapy for Alzheimer's disease: past, present and future | Q38222750 | ||
| Genetic factors associated with longevity: a review of recent findings | Q38275055 | ||
| Compromised autophagy and neurodegenerative diseases | Q38492623 | ||
| Microglial brain region-dependent diversity and selective regional sensitivities to aging. | Q38642851 | ||
| Aging-associated changes in human brain | Q41669704 | ||
| Systemic regulation of the age-related decline of pancreatic β-cell replication | Q41842271 | ||
| MHC class I: an unexpected role in neuronal plasticity | Q42115670 | ||
| Enhancement of memories by systemic administration of insulin-like growth factor II. | Q42740389 | ||
| Eotaxin and obesity | Q42808492 | ||
| Pathological stress granules in Alzheimer's disease | Q43056232 | ||
| One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women | Q43571560 | ||
| Aβ secretion and plaque formation depend on autophagy | Q44061458 | ||
| P433 | issue | 7628 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| neurodegeneration | Q1755122 | ||
| P304 | page(s) | 180-186 | |
| P577 | publication date | 2016-11-10 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Ageing, neurodegeneration and brain rejuvenation | |
| P478 | volume | 539 |
| Q47872845 | "Understanding the Role of Hypoxia inducible factor during neurodegeneration for new therapeutics opportunities". |
| Q52431215 | A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington's Disease. |
| Q57188247 | A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain |
| Q90561593 | A hormone receptor pathway cell-autonomously delays neuron morphological aging by suppressing endocytosis |
| Q49578602 | A transcriptomic atlas of aged human microglia. |
| Q62748361 | Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain |
| Q59126043 | Advanced model systems and tools for basic and translational human immunology |
| Q92381661 | Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease |
| Q92523995 | Age- and stress-associated C. elegans granulins impair lysosomal function and induce a compensatory HLH-30/TFEB transcriptional response |
| Q92001084 | Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1 |
| Q90003697 | Ageing as a risk factor for neurodegenerative disease |
| Q49372792 | Aging and the Krüppel-like factors. |
| Q60923331 | Bioassay for monitoring the anti-aging effect of cord blood treatment |
| Q46250174 | Black Phosphorus Nanosheets as a Neuroprotective Nanomedicine for Neurodegenerative Disorder Therapy. |
| Q98725888 | Blood substitution therapy rescues the brain of mice from ischemic damage |
| Q90745439 | Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis |
| Q54953232 | Brain Mitochondria, Aging, and Parkinson's Disease. |
| Q42364364 | CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease. |
| Q88308572 | Caloric restriction mitigates age-associated hippocampal differential CG and non-CG methylation |
| Q52586031 | Can Curcumin Counteract Cognitive Decline? Clinical Trial Evidence and Rationale for Combining ω-3 Fatty Acids with Curcumin. |
| Q38643560 | Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia |
| Q92513138 | Cell Type Specific Expression of Toll-Like Receptors in Human Brains and Implications in Alzheimer's Disease |
| Q96816564 | Cellular senescence and Alzheimer disease: the egg and the chicken scenario |
| Q54217784 | Chemical compound-based direct reprogramming for future clinical applications. |
| Q57050335 | Chronic noise exposure exacerbates AD-like neuropathology in SAMP8 mice in relation to Wnt signaling in the PFC and hippocampus |
| Q90331275 | Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and rescue of endothelial function by young blood |
| Q47119516 | Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins. |
| Q92259337 | Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly |
| Q41573979 | Comparative Studies on Behavioral, Cognitive and Biomolecular Profiling of ICR, C57BL/6 and Its Sub-Strains Suitable for Scopolamine-Induced Amnesic Models. |
| Q64119240 | Connecting Metainflammation and Neuroinflammation Through the PTN-MK-RPTPβ/ζ Axis: Relevance in Therapeutic Development |
| Q54205666 | Connections of annexin A1 and translocator protein-18 kDa on toll like receptor stimulated BV-2 cells. |
| Q102220208 | Decoding individual identity from brain activity elicited in imagining common experiences |
| Q55715569 | Deficiency in the transcription factor NRF2 worsens inflammatory parameters in a mouse model with combined tauopathy and amyloidopathy. |
| Q64111365 | Deficits in Social Behavior Precede Cognitive Decline in Middle-Aged Mice |
| Q64117846 | Designing and Characterization of a Novel Delivery System for Improved Cellular Uptake by Brain Using Dendronised Apo-E-Derived Peptide |
| Q61798592 | Dose-response relationship between exercise and cognitive function in older adults with and without cognitive impairment: A systematic review and meta-analysis |
| Q96110145 | Effect of a multicomponent exercise intervention on brain metabolism: A randomized controlled trial on Alzheimer's pathology (Dementia-MOVE) |
| Q64237552 | Effects of Thioflavin T and GSK-3 Inhibition on Lifespan and Motility in a Model of Tauopathy |
| Q58799729 | Estimation of the cancer risk induced by therapies targeting stem cell replication and treatment recommendations |
| Q63245460 | Evaluation of the Antioxidant and Neuroprotectant Activities of New Asymmetrical 1,3-Diketones |
| Q48043354 | Exceptional in vivo catabolism of neurodegeneration-related aggregates |
| Q89701192 | FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism |
| Q50115461 | Framework for Considering Productive Aging at Work. |
| Q97882884 | GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment |
| Q58700782 | Gene Expression Analysis Reveals Novel Gene Signatures Between Young and Old Adults in Human Prefrontal Cortex |
| Q90220217 | Genome editing methods in animal models |
| Q95840660 | Genome-Wide Screen of the Hippocampus in Aged Rats Identifies Mitochondria, Metabolism and Aging Processes Implicated in Sevoflurane Anesthesia |
| Q90736866 | Ginkgo biloba Prevents Oxidative Stress-Induced Apoptosis Blocking p53 Activation in Neuroblastoma Cells |
| Q98577050 | Ginseng gintonin, aging societies, and geriatric brain diseases |
| Q38600419 | Gray matter structural networks are associated with cardiovascular risk factors in healthy older adults |
| Q59333076 | Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice |
| Q58765738 | Horizons in the evolution of aging |
| Q64287877 | Hyperactive Innate Immunity Causes Degeneration of Dopamine Neurons upon Altering Activity of Cdk5 |
| Q64261557 | Hyperoxygenation revitalizes Alzheimer's disease pathology through the upregulation of neurotrophic factors |
| Q91646668 | Hypoxia-Induced Degenerative Protein Modifications Associated with Aging and Age-Associated Disorders |
| Q47382007 | Ifngr1 and Stat1 mediated canonical Ifn-γ signaling drives nigrostriatal degeneration |
| Q90369806 | Impact of Long-Term RF-EMF on Oxidative Stress and Neuroinflammation in Aging Brains of C57BL/6 Mice |
| Q92994454 | Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence |
| Q41140219 | Interplay of Energetics and ER Stress Exacerbates Alzheimer's Amyloid-β (Aβ) Toxicity in Yeast |
| Q64888123 | Involvement of p38 in Age-Related Decline in Adult Neurogenesis via Modulation of Wnt Signaling. |
| Q59812412 | Is Alzheimer's Also a Stem Cell Disease? - The Zebrafish Perspective |
| Q49545472 | Kynurenic acid accumulation underlies learning and memory impairment associated with aging. |
| Q57799708 | Lipid profiling of C. elegans strains administered pro-longevity drugs and drug combinations |
| Q54455762 | Long Non-Coding RNAs in Neuronal Aging. |
| Q43375858 | Markers of Alzheimer's Disease in Primary Visual Cortex in Normal Aging in Mice |
| Q61816980 | Material and Structural Modeling Aspects of Brain Tissue Deformation under Dynamic Loads |
| Q64119705 | Matter over mind: Liquid phase separation and neurodegeneration |
| Q55496634 | Metabolic enzymes in glial cells of the honeybee brain and their associations with aging, starvation and food response. |
| Q90579247 | Metallotexaphyrins as MRI-Active Catalytic Antioxidants for Neurodegenerative Disease: A Study on Alzheimer's Disease |
| Q88920896 | Mitochondrial Aging Defects Emerge in Directly Reprogrammed Human Neurons due to Their Metabolic Profile |
| Q47123936 | Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease. |
| Q91667311 | Monitoring metal-amyloid-β complexation by a FRET-based probe: design, detection, and inhibitor screening |
| Q47251476 | Multi-Protection of DL0410 in Ameliorating Cognitive Defects in D-Galactose Induced Aging Mice |
| Q88725530 | Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics |
| Q57288794 | Multiplication of the SNCA locus exacerbates neuronal nuclear aging |
| Q64120496 | Neural Plasticity during Aging |
| Q39335873 | Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System |
| Q42344614 | Neurodegenerative disease: models, mechanisms, and a new hope. |
| Q64073405 | Neuroinflammation and Perioperative Neurocognitive Disorders |
| Q64100444 | Neuroprotective Effect of Dioscin on the Aging Brain |
| Q92770486 | New terminology for a common TDP-43 proteinopathy |
| Q90754400 | Normal tension glaucoma-like degeneration of the visual system in aged marmosets |
| Q94450771 | Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study |
| Q53397884 | Odor Enrichment Increases Hippocampal Neuron Numbers in Mouse. |
| Q33624540 | Old Maids: Aging and Its Impact on Microglia Function |
| Q98563342 | Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders |
| Q93138367 | Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases |
| Q57039635 | Peripheral immune system in aging and Alzheimer's disease |
| Q90644110 | Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease? |
| Q89683184 | Potential Protective Role Exerted by Secoiridoids from Olea europaea L. in Cancer, Cardiovascular, Neurodegenerative, Aging-Related, and Immunoinflammatory Diseases |
| Q41585770 | Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified |
| Q92596330 | Protective Effects of Hydrolyzed Chicken Extract (Probeptigen®/Cmi-168) on Memory Retention and Brain Oxidative Stress in Senescence-Accelerated Mice |
| Q92416204 | Protein-based amide proton transfer-weighted MR imaging of amnestic mild cognitive impairment |
| Q48143800 | Puerarin and Amlodipine Improvement of D-Galactose-Induced Impairments of Behaviour and Neurogenesis in Mouse Dentate Gyrus: Correlation with Glucocorticoid Receptor Expression |
| Q46092009 | RNA targeting with CRISPR-Cas13. |
| Q60950137 | Repairing the Brain: Gene Therapy |
| Q30234641 | Role of circulating factors in cardiac aging. |
| Q90263029 | Single-cell transcriptomic profiling of the aging mouse brain |
| Q96302713 | Spatially-resolved metabolic profiling of living Drosophila in neurodegenerative conditions using 1H magic angle spinning NMR |
| Q92501090 | Specific factors in blood from young but not old mice directly promote synapse formation and NMDA-receptor recruitment |
| Q57157667 | Stem cell therapy for neurological disorders: A focus on aging |
| Q47717967 | Stem cells: Aging and transcriptional fingerprints |
| Q38373457 | Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly |
| Q90296581 | Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders |
| Q51758684 | The Aging of Iron Man. |
| Q92354128 | The cGAS/STING pathway: a sensor of senescence-associated DNA damage and trigger of inflammation in early age-related macular degeneration |
| Q48221587 | The effects of aging on Amyloid-β42-induced neurodegeneration and regeneration in adult zebrafish brain. |
| Q95936711 | The quest to slow ageing through drug discovery |
| Q46268121 | The role of mitochondrial ROS in the aging brain |
| Q41208095 | Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease. |
| Q89036250 | Tissue-Specific Upregulation of Drosophila Insulin Receptor (InR) Mitigates Poly(Q)-Mediated Neurotoxicity by Restoration of Cellular Transcription Machinery |
| Q92522957 | Transcriptome analysis of the hippocampus in environmental noise-exposed SAMP8 mice reveals regulatory pathways associated with Alzheimer's disease neuropathology |
| Q91559758 | Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond |
| Q92635625 | Uncovering the Pharmacological Mechanism of Stemazole in the Treatment of Neurodegenerative Diseases Based on a Network Pharmacology Approach |
| Q92796940 | Use of large animal models to investigate Huntington's diseases |
| Q90698963 | VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells |
| Q64069093 | Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints |
| Q46252338 | Vertebrate food products as a potential source of prion-like α-synuclein. |
| Q58602514 | Young and aged TLR4 deficient mice show sex-dependent enhancements in spatial memory and alterations in interleukin-1 related genes |
| Q53397794 | Young blood products: emerging treatment for Alzheimer's disease? |
| Q64262792 | Young plasma ameliorates aging-related acute brain injury after intracerebral hemorrhage |
Search more.